{"DataElement":{"publicId":"7413938","version":"1","preferredName":"Procedure Domain Reported Car T-cell Therapy Type","preferredDefinition":"The verbatim surgical, therapeutic, or diagnostic procedure's name for CAR T-cell therapy.","longName":"PR_PRTRT_CART","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"6411454","version":"1","preferredName":"Procedure Domain Reported Name of Procedure","preferredDefinition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to procedure._The literal identifier of the procedure.","longName":"6407261v1.0:6411452v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"6407261","version":"1","preferredName":"Procedure Domain","preferredDefinition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to procedure.","longName":"C102700","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Procedure Domain","conceptCode":"C102700","definition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to procedure.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"73F3626C-19A3-3896-E053-F662850A4518","latestVersionIndicator":"Yes","beginDate":"2018-08-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-21","modifiedBy":"ONEDATA","dateModified":"2018-08-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6411452","version":"1","preferredName":"Reported Name of Procedure","preferredDefinition":"The literal identifier of the procedure.","longName":"C117511","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Reported Name of Procedure","conceptCode":"C117511","definition":"The literal identifier of the procedure.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"74229DA7-7B00-77CA-E053-F662850AEC9E","latestVersionIndicator":"Yes","beginDate":"2018-08-23","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-08-23","modifiedBy":"ONEDATA","dateModified":"2018-08-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435019","version":"1","preferredName":"Conceptual Entity","preferredDefinition":"An organizational header for concepts representing mostly abstract entities.","longName":"C20181","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D8-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CDISC:Clinical Data Interchange Standards Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"74229DA7-7B11-77CA-E053-F662850AEC9E","latestVersionIndicator":"Yes","beginDate":"2018-08-23","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-08-23","modifiedBy":"TAYLORT","dateModified":"2020-07-20","changeDescription":"7-20-20 tmt released. Created as part of the CDISC mapping task_ghd_08.23.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6835487","version":"1","preferredName":"Car T-cell Therapy Type","preferredDefinition":"Something distinguishable as an identifiable class based on common qualities.","longName":"6835487v1.0","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Tisagen","valueDescription":"Adoptive Immunotherapy","ValueMeaning":{"publicId":"6835489","version":"1","preferredName":"Adoptive Immunotherapy","longName":"6835489","preferredDefinition":"A treatment used to help the immune system fight diseases, such as cancer and infections with certain viruses. T cells are collected from a patient and grown in the laboratory. This increases the number of T cells that are able to kill cancer cells or fight infections. These T cells are given back to the patient to help the immune system fight disease.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adoptive Immunotherapy","conceptCode":"C15351","definition":"A technique for enhancing cell-mediated immunity by: 1) artificially increasing the number of specific immunocompetent cells through inoculation of either ex-vivo expanded primarily activated cytotoxic lymphocytes or genetically engineered lymphocytes with enhanced cytotoxic ability or 2) by altering tumor cells to make them more immunogenic.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8ED49CAA-B836-702F-E053-F662850AC890","latestVersionIndicator":"Yes","beginDate":"2019-07-29","endDate":null,"createdBy":"SORTILLD","dateCreated":"2019-07-29","modifiedBy":"ONEDATA","dateModified":"2019-07-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8ED55897-01FA-1F73-E053-F662850AF413","beginDate":"2019-07-29","endDate":null,"createdBy":"SORTILLD","dateCreated":"2019-07-29","modifiedBy":"ONEDATA","dateModified":"2019-07-29","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"6424136","version":"1","preferredName":"Other","longName":"6424136","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"753441A1-068C-5A23-E053-F662850A6B7A","latestVersionIndicator":"Yes","beginDate":"2018-09-06","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-09-06","modifiedBy":"KUMMEROA","dateModified":"2023-02-02","changeDescription":null,"administrativeNotes":"2023.2.2 Alt VM added per ticket request CADSR0002006. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8ED49CAA-B829-702F-E053-F662850AC890","beginDate":"2019-07-29","endDate":null,"createdBy":"SORTILLD","dateCreated":"2019-07-29","modifiedBy":"ONEDATA","dateModified":"2019-07-29","deletedIndicator":"No"},{"value":"Axigen","valueDescription":"Adoptive Immunotherapy","ValueMeaning":{"publicId":"6835489","version":"1","preferredName":"Adoptive Immunotherapy","longName":"6835489","preferredDefinition":"A treatment used to help the immune system fight diseases, such as cancer and infections with certain viruses. T cells are collected from a patient and grown in the laboratory. This increases the number of T cells that are able to kill cancer cells or fight infections. These T cells are given back to the patient to help the immune system fight disease.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adoptive Immunotherapy","conceptCode":"C15351","definition":"A technique for enhancing cell-mediated immunity by: 1) artificially increasing the number of specific immunocompetent cells through inoculation of either ex-vivo expanded primarily activated cytotoxic lymphocytes or genetically engineered lymphocytes with enhanced cytotoxic ability or 2) by altering tumor cells to make them more immunogenic.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8ED49CAA-B836-702F-E053-F662850AC890","latestVersionIndicator":"Yes","beginDate":"2019-07-29","endDate":null,"createdBy":"SORTILLD","dateCreated":"2019-07-29","modifiedBy":"ONEDATA","dateModified":"2019-07-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8ED49CAA-B84F-702F-E053-F662850AC890","beginDate":"2019-07-29","endDate":null,"createdBy":"SORTILLD","dateCreated":"2019-07-29","modifiedBy":"ONEDATA","dateModified":"2019-07-29","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8ED49CAA-B812-702F-E053-F662850AC890","latestVersionIndicator":"Yes","beginDate":"2019-07-29","endDate":null,"createdBy":"SORTILLD","dateCreated":"2019-07-29","modifiedBy":"GDEEN","dateModified":"2022-10-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"What was the type of CAR T-ce","type":"Preferred Question Text","description":"What was the type of CAR T-cell therapy?","url":null,"context":"COG"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AED4AA27-C952-5FA3-E053-4EBD850AB077","latestVersionIndicator":"Yes","beginDate":"2020-09-08","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2020-09-08","modifiedBy":"SETRAKIN","dateModified":"2020-09-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}